Associations of Vitamin D-binding globulin and bioavailable Vitamin D concentrations with coronary heart disease events: The Multi-Ethnic Study of Atherosclerosis (MESA)

Journal of Clinical Endocrinology and Metabolism

Volumn 102, Issue 8, 2017, Pages 3075-3084

  Robinson Cohen, Cassianne ^a,m   Zelnick, Leila R ^a   Hoofnagle, Andrew N ^b   Lutsey, Pamela L ^c   Burke, Gregory ^d   Michos, Erin D ^e,f   Shea, Steven J C ^g,h   Tracy, Russell ^i,j   Siscovick, David S ^k   Psaty, Bruce ^a,b,l   Kestenbaum, Bryan ^a   De Boer, Ian H ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g New York Presbyterian Columbia University Medical Center   (United States)

^h Department of Medicine   (United States)

ⁱ UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF VERMONT   (United States)

^k NEW YORK ACADEMY OF MEDICINE   (United States)

^l GROUP HEALTH RESEARCH INSTITUTE   (United States)

^m NONE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D BINDING PROTEIN; 25-HYDROXYVITAMIN D; ISOPROTEIN; VITAMIN D;

ADULT; ARTICLE; BIOAVAILABILITY; BLACK PERSON; CARDIOVASCULAR RISK; CASE STUDY; CAUCASIAN; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; ETHNICITY; FEMALE; FOLLOW UP; HISPANIC; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE; AFRICAN AMERICAN; AGED; ANALOGS AND DERIVATIVES; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CASE CONTROL STUDY; CORONARY DISEASE; MASS SPECTROMETRY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; UNITED STATES; VERY ELDERLY;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL AVAILABILITY; CASE-CONTROL STUDIES; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROTEIN ISOFORMS; RISK FACTORS; UNITED STATES; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 85026900271     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2017-00296     Document Type: Article

References (50)

1. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168(12):1340-1349.
2. de Boer IH, Levin G, Robinson-Cohen C, Biggs ML, Hoofnagle AN, Siscovick DS, Kestenbaum B. Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study. Ann Intern Med. 2012;156(9):627-634.
3. Kestenbaum B, Katz R, de Boer I, Hoofnagle A, Sarnak MJ, Shlipak MG, Jenny NS, Siscovick DS. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol. 2011;58(14):1433-1441.
4. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503-511.
5. Hutchinson MS, Grimnes G, Joakimsen RM, Figenschau Y, Jorde R. Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromsø study. Eur J Endocrinol. 2010;162(5):935-942.
6. Liu L, Chen M, Hankins SR, Nùñez AE, Watson RA, Weinstock PJ, Newschaffer CJ, Eisen HJ; Drexel Cardiovascular Health Collaborative Education, Research, and Evaluation Group. Serum 25-hydroxyvitamin D concentration and mortality from heart failure and cardiovascular disease, and premature mortality fromallcause in United States adults. Am J Cardiol. 2012;110(6):834-839.
7. Robinson-Cohen C, Hoofnagle AN, Ix JH, Sachs MC, Tracy RP, Siscovick DS, Kestenbaum BR, de Boer IH. Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA. 2013;310(2):179-188.
8. Michos ED, Reis JP, Post WS, Lutsey PL, Gottesman RF, Mosley TH, Sharrett AR, Melamed ML. 25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES-III linked mortality files. Nutrition. 2012;28(4): 367-371.
9. Lutsey PL, Michos ED, Misialek JR, Pankow JS, Loehr L, Selvin E, Reis JP, Gross M, Eckfeldt JH, Folsom AR. Race and vitamin D binding protein gene polymorphisms modify the association of 25-hydroxyvitamin D and incident heart failure: The ARIC (Atherosclerosis Risk in Communities) Study. JACC Heart Fail. 2015; 3(5):347-356.
10. Scragg R, Sowers M, Bell C; Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27(12):2813-2818.
11. Reis JP, Michos ED, von Mühlen D, Miller ER III. Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am J Clin Nutr. 2008;88(6):1469-1477.
12. van Ballegooijen AJ, Robinson-Cohen C, Katz R, Criqui M, Budoff M, Li D, Siscovick D, Hoofnagle A, Shea SJ, Burke G, de Boer IH, Kestenbaum B. Vitamin D metabolites and bone mineral density: the Multi-Ethnic Study of Atherosclerosis. Bone. 2015;78: 186-193.
13. Michos ED, Misialek JR, Selvin E, Folsom AR, Pankow JS, Post WS, Lutsey PL. 25-hydroxyvitamin D levels, vitamin D binding protein gene polymorphisms and incident coronary heart disease among whites and blacks: the ARIC study. Atherosclerosis. 2015; 241(1):12-17.
14. Bikle DD, Siiteri PK, Ryzen E, Haddad JG. Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab. 1985;61(5): 969-975.
15. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab. 1986;63(4):954-959.
16. Kamboh MI, Ferrell RE. Ethnic variation in vitamin D-binding protein (GC): a review of isoelectric focusing studies in human populations. Hum Genet. 1986;72(4):281-293.
17. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi SA, Powe NR, Thadhani R. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013; 369(21):1991-2000.
18. Henderson CM, Lutsey PL, Misialek JR, Laha TJ, Selvin E, Eckfeldt JH, Hoofnagle AN. Measurement by a novel LC-MS/MS methodology reveals similar serum concentrations of vitamin D-binding protein in blacks and whites. Clin Chem. 2016;62(1):179-187.
19. Denburg MR, Hoofnagle AN, Sayed S, Gupta J, de Boer IH, Appel LJ, Durazo-Arvizu R, Whitehead K, Feldman HI, Leonard MB; Chronic Renal Insufficiency Cohort study investigators. Comparison of two ELISA methods and mass spectrometry for measurement of vitamin D-binding protein: implications for the assessment of bioavailable vitamin D concentrations across genotypes. J Bone Miner Res. 2016;31(6):1128-1136.
20. Hoofnagle AN, Eckfeldt JH, Lutsey PL. Vitamin D-binding protein concentrations quantified by mass spectrometry. N Engl J Med. 2015;373(15):1480-1482.
21. Nielson CM, Jones KS, Chun RF, Jacobs JM, Wang Y, Hewison M, Adams JS, Swanson CM, Lee CG, Vanderschueren D, Pauwels S, Prentice A, Smith RD, Shi T, Gao Y, Schepmoes AA, Zmuda JM, Lapidus J, Cauley JA, Bouillon R, Schoenmakers I, Orwoll ES; Osteoporotic Fractures in Men (MrOS) Research Group. Free 25-hydroxyvitamin D: impact of vitamin D binding protein assays on racial-genotypic associations. J Clin Endocrinol Metab. 2016; 101(5):2226-2234.
22. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR Jr, Kronmal R, Liu K, Nelson JC, O'Leary D, Saad MF, Shea S, Szklo M, Tracy RP. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002;156(9):871-881.
23. Budoff MJ, Nasir K, Katz R, Takasu J, Carr JJ, Wong ND, Allison M, Lima JA, Detrano R, Blumenthal RS, Kronmal R. Thoracic aortic calcification and coronary heart disease events: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2011; 215(1):196-202.
24. Lutsey PL, Parrinello CM, Misialek JR, Hoofnagle AN, Henderson CM, Laha TJ, Michos ED, Eckfeldt JH, Selvin E. Short-term variability of vitamin D-related biomarkers. Clin Chem. 2016; 62(12):1647-1653.
25. Sachs MC, Shoben A, Levin GP, Robinson-Cohen C, Hoofnagle AN, Swords-Jenny N, Ix JH, Budoff M, Lutsey PL, Siscovick DS, Kestenbaum B, de Boer IH. Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr. 2013;97(6): 1243-1251.
26. Phinney KW. Development of a standard reference material for vitamin D in serum. Am J Clin Nutr. 2008;88(2):511S-512S.
27. Bhan I, Powe CE, Berg AH, Ankers E, Wenger JB, Karumanchi SA, Thadhani RI. Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients. Kidney Int. 2012;82(1):84-89.
28. Johnsen MS, Grimnes G, Figenschau Y, Torjesen PA, Almås B, Jorde R. Serum free and bio-available 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D[published correction appears in Scand JClin Lab Invest. 2014;74(5): 464]. Scand J Clin Lab Invest. 2014;74(3):177-183.
29. American Diabetes Association. Standards of medical care in diabetes: 2007. Diabetes Care. 2007;30(suppl 1):S4-S41.
30. Bosworth C, Sachs MC, Duprez D, Hoofnagle AN, Ix JH, Jacobs DR Jr, Peralta CA, Siscovick DS, Kestenbaum B, de Boer IH. Parathyroid hormone and arterial dysfunction in the Multi-Ethnic Study of Atherosclerosis. Clin Endocrinol (Oxf). 2013;79(3): 429-436.
31. Linefsky JP, O'Brien KD, Katz R, de Boer IH, Barasch E, Jenny NS, Siscovick DS, Kestenbaum B. Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the Cardiovascular Health Study. J Am Coll Cardiol. 2011;58(3):291-297.
32. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012; 367(1):20-29.
33. Royston P. Multiple imputation of missing values. Stata J. 2004; 4(3):227-241.
34. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: Wiley; 1987.
35. Therneau TM, Li H. Computing the Cox model for case cohort designs. Lifetime Data Anal. 1999;5(2):99-112.
36. Barlow WE. Robust variance estimation for the case-cohort design. Biometrics. 1994;50(4):1064-1072.
37. Prentice R. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika. 1986;73:1-11.
38. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. Boca Raton, FL: CRC Press; 1994.
39. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2016.
40. Petrone AB, Weir NL, Steffen BT, Tsai MY, Gaziano JM, Djoussé L. Plasma vitamin D-binding protein and risk of heart failure in male physicians. Am J Cardiol. 2013;112(6):827-830.
41. Rebholz CM, Grams ME, Lutsey PL, Hoofnagle AN, Misialek JR, Inker LA, Levey AS, Selvin E, Hsu CY, Kimmel PL, Vasan RS, Eckfeldt JH, Coresh J; Chronic Kidney Disease Biomarkers Consortium. Biomarkers of vitamin D status and risk of ESRD. Am J Kidney Dis. 2016;67(2):235-242.
42. Lee WM, Galbraith RM, Watt GH, Hughes RD, McIntire DD, Hoffman BJ, Williams R. Predicting survival in fulminant hepatic failure using serum Gc protein concentrations. Hepatology. 1995; 21(1):101-105.
43. Antoniades CG, Berry PA, Bruce M, Cross TJ, Portal AJ, Hussain MJ, Bernal W, Wendon JA, Vergani D. Actin-free Gc globulin: a rapidly assessed biomarker of organ dysfunction in acute liver failure and cirrhosis. Liver Transpl. 2007;13(9): 1254-1261.
44. Bagchi A, Kumar S, Ray PC, Das BC, Gumma PK, Kar P. Predictive value of serum actin-free Gc-globulin for complications and outcome in acute liver failure. J Viral Hepat. 2015;22(2):192-200.
45. Bagchi S, Oniku AE, Topping K, Mamhoud ZN, Paget TA. Programmed cell death in Giardia. Parasitology. 2012;139(7): 894-903.
46. Zella LA, Shevde NK, Hollis BW, Cooke NE, Pike JW. Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology. 2008;149(7):3656-3667.
47. Dahl OE, Gudmundsen TE, Bjørnarå BT, Solheim DM. Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital: a 10-year prospective register of 3,954 patients. Acta Orthop Scand. 2003;74(3):299-304.
48. Dahl B, Schiødt FV, Rudolph S, Ott P, Kiaer T, Heslet L. Trauma stimulates the synthesis of Gc-globulin. Intensive Care Med. 2001; 27(2):394-399.
49. Gomme PT, Bertolini J. Therapeutic potential of vitamin D-binding protein. Trends Biotechnol. 2004;22(7):340-345.
50. Powe CE, Ricciardi C, Berg AH, Erdenesanaa D, Collerone G, Ankers E, Wenger J, Karumanchi SA, Thadhani R, Bhan I. Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res. 2011;26(7):1609-1616.